Cato Jacobs

812 total citations
8 papers, 146 citations indexed

About

Cato Jacobs is a scholar working on Infectious Diseases, Epidemiology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Cato Jacobs has authored 8 papers receiving a total of 146 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Infectious Diseases, 5 papers in Epidemiology and 3 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Cato Jacobs's work include Antifungal resistance and susceptibility (5 papers), Fungal Infections and Studies (4 papers) and Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (2 papers). Cato Jacobs is often cited by papers focused on Antifungal resistance and susceptibility (5 papers), Fungal Infections and Studies (4 papers) and Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (2 papers). Cato Jacobs collaborates with scholars based in Belgium, United Kingdom and Netherlands. Cato Jacobs's co-authors include Joost Wauters, Lore Vanderbeke, Philip C. Hill, Paul Kelly, Samreen Ijaz, Katrien Lagrou, Greet Hermans, Philippe Meersseman, Laura Seldeslachts and Stéphanie Humblet‐Baron and has published in prestigious journals such as American Journal of Respiratory and Critical Care Medicine, Clinical Infectious Diseases and The Journal of Infectious Diseases.

In The Last Decade

Cato Jacobs

8 papers receiving 145 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Cato Jacobs Belgium	7	106	72	28	24	16	8	146
Patricia Meza-Meneses Mexico	7	89 0.8×	47 0.7×	8 0.3×	6 0.3×	6 0.4×	12	125
Minya Lu China	8	109 1.0×	68 0.9×	24 0.9×	2 0.1×	7 0.4×	17	159
Erika Silvestro Italy	6	33 0.3×	22 0.3×	31 1.1×	7 0.3×	10 0.6×	12	147
Zhengyin Liu China	7	24 0.2×	65 0.9×	13 0.5×	10 0.4×	30 1.9×	21	132
Luz Helena Gutierrez Sanchez United States	6	95 0.9×	81 1.1×	15 0.5×	7 0.3×	13 0.8×	9	131
Mohammad Hossein Zamanian Iran	6	63 0.6×	26 0.4×	5 0.2×	6 0.3×	11 0.7×	28	132
Elisa Balletto Italy	7	143 1.3×	80 1.1×	16 0.6×	2 0.1×	11 0.7×	11	236
Esma Eren Türkiye	7	50 0.5×	45 0.6×	12 0.4×		7 0.4×	39	120
Gráinne Tuite Ireland	6	138 1.3×	23 0.3×	10 0.4×	20 0.8×	7 0.4×	8	166
H. Bentayeb France	6	38 0.4×	27 0.4×	37 1.3×	5 0.2×	8 0.5×	12	128

Countries citing papers authored by Cato Jacobs

Since Specialization

Citations

This map shows the geographic impact of Cato Jacobs's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cato Jacobs with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cato Jacobs more than expected).

Fields of papers citing papers by Cato Jacobs

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Cato Jacobs. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cato Jacobs. The network helps show where Cato Jacobs may publish in the future.

Co-authorship network of co-authors of Cato Jacobs

This figure shows the co-authorship network connecting the top 25 collaborators of Cato Jacobs. A scholar is included among the top collaborators of Cato Jacobs based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Cato Jacobs. Cato Jacobs is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

8 of 8 papers shown

Cambier, Seppe, Noëmie Pörtner, Mieke Metzemaekers, et al.. (2023). Proteolytic inactivation of CXCL12 in the lungs and circulation of COVID-19 patients. Cellular and Molecular Life Sciences. 80(8). 234–234. 6 indexed citations

Feys, Simon, Katrien Lagrou, Cato Jacobs, et al.. (2023). High Burden of COVID-19-Associated Pulmonary Aspergillosis in Severely Immunocompromised Patients Requiring Mechanical Ventilation. Clinical Infectious Diseases. 78(2). 361–370. 21 indexed citations

Vanderbeke, Lore, Cato Jacobs, Simon Feys, et al.. (2023). A Pathology-based Case Series of Influenza- and COVID-19–associated Pulmonary Aspergillosis: The Proof Is in the Tissue. American Journal of Respiratory and Critical Care Medicine. 208(3). 301–311. 15 indexed citations

Daele, Ruth Van, Joost Wauters, Erwin Dreesen, et al.. (2022). Exposure to intravenous posaconazole in critically ill patients with influenza: A pharmacokinetic analysis of the POSA‐FLU study. Mycoses. 65(6). 656–660. 6 indexed citations

Cambier, Seppe, Mieke Metzemaekers, Cato Jacobs, et al.. (2021). Atypical response to bacterial coinfection and persistent neutrophilic bronchoalveolar inflammation distinguish critical COVID-19 from influenza. JCI Insight. 7(1). 39 indexed citations

Seldeslachts, Laura, Cato Jacobs, Stéphanie Humblet‐Baron, et al.. (2021). Overcome Double Trouble: Baloxavir Marboxil Suppresses Influenza Thereby Mitigating Secondary Invasive Pulmonary Aspergillosis. Journal of Fungi. 8(1). 1–1. 9 indexed citations

Seldeslachts, Laura, Lore Vanderbeke, Agustin Reséndiz-Sharpe, et al.. (2021). Early oseltamivir reduces risk for influenza-associated aspergillosis in a double-hit murine model. Virulence. 12(1). 2493–2508. 22 indexed citations

Jacobs, Cato, et al.. (2013). Seroepidemiology of Hepatitis E Virus Infection in an Urban Population in Zambia: Strong Association With HIV and Environmental Enteropathy. The Journal of Infectious Diseases. 209(5). 652–657. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact